Company intelligence / Profile preview

Biological Defense

Fairfax, Virginia, United States

Ownership: Private
Development stage: Other

Overview

Biological Defense is a specialized company focused on providing comprehensive solutions for protection against biological, chemical, and nuclear threats. Founded in the aftermath of the 9/11 attacks, the company researches and develops highly protective kits designed for immediate use by individuals, families, and institutions during weapons of mass destruction (WMD) events or natural disasters. Their product line includes specialized biological defense kits that contain medical supplies, protective gear, and survival items tailored to mitigate the impact of pathogens like anthrax and smallpox. The company operates primarily in the biodefense and emergency preparedness sectors, serving both civilian and government needs.

Therapeutic areas: Infectious Diseases
Modalities: DeviceVaccine
Industry: Biotech

Beyond the preview

Go deeper on Biological Defense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological Defense.

Explore the full profile